Flu Vaccine Antibodies 2018

Lab Reagents

Human IgG antibody Laboratories manufactures the flu vaccine antibodies 2018 reagents distributed by Genprice. The Flu Vaccine Antibodies 2018 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact influenza Antibody. Other Flu products are available in stock. Specificity: Flu Category: Vaccine Group: Antibodies 2018

Antibodies 2018 information

FLU-A DOT-ELISA Kit

DEIA436 6T/30T
EUR 580
Description: This kit is an in vitro immunoassay test (Dot-ELISA) for the direct, rapid and qualitative detection of nucleoprotein (NP) antigen of Influenza A Virus in human nasopharyngeal aspirates, swabs, nasal wash, chicken embryo whole virus inoculation or viral lysates, etc. It is intended for clinical identification influenza type-A viruses.

Guinea Pig FLU ELISA Kit

EGF0241 96Tests
EUR 521

Human FLU-H5 ELISA Kit

201-12-2128 96 tests
EUR 440
  • This FLU-H5 ELISA kit is validated to work with samples from whole blood, serum, plasma and cell culture supernatant.
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Human FLU-H5 ELISA Kit

QY-E04880 96T
EUR 361

Saponin Vaccine Adjuvant

VAdv-Ly0009 1 g
EUR 1095
Description: Saponin Vaccine Adjuvant, plant-based vaccine adjuvant.

Recombinant flagellin FlicC vaccine adjuvant (TLR5 agonist); vaccine adjuvant

AV-7010-50 50 ug
EUR 895

Avian Flu (H5N1) Protein Detection Set

PSI-1808 1 Set
EUR 737
  • Optimal dilutions for each application to be determined by the researcher.
Description: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA. Novel influenza virus strains emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. Although it has been known that cleavage site and glycosylation patterns of the HA protein play important roles in determining the pathogenicity of H5 avian influenza viruses, it has only recently been shown that an additional glycosylation site within the globular head of the neuraminidase protein also contributes to the high virulence of the H5N1 virus. H5N1 hemagglutinin interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability.;;For images please see PDF data sheet

Calcium phosphate vaccine adjuvant

AV-1020-100 100 ml
EUR 219

Peanut Oil vaccine adjuvant

AV-5010-50 50 ml
EUR 225

Mineral Oil vaccine adjuvant

AV-5020-50 50 ml
EUR 225

Mannide monooleate vaccine adjuvant

AV-5030-5 5 g
EUR 164

HS15 Kolliphore vaccine adjuvant

AV-6010-100 100 g
EUR 286

Pam2CSK4 vaccine adjuvant, unlabeled

AV-9020-1 1 mg
EUR 408

Pam3CSK4 vaccine adjuvant, unlabeled

AV-9025-1 1 mg
EUR 286

Human Influenza viruses IgG(FLU)ELISA Kit

GA-E1783HM-48T 48T
EUR 289

Human Influenza viruses IgG(FLU)ELISA Kit

GA-E1783HM-96T 96T
EUR 466

Human Influenza viruses IgG,FLU ELISA Kit

201-12-1767 96 tests
EUR 440
  • This Influenza viruses IgG ELISA kit is validated to work with samples from whole blood, serum, plasma and cell culture supernatant.
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.